ArticleInternational journal of nanomedicine2024
Black Phosphorus Nanosheets-Loaded Single-Atom Gold Nanoenzymes for Enhanced Photodynamic Therapy of Hepatocellular Carcinoma.
Article in International journal of nanomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Innovative Strategies to Overcome Stability Challenges of Single-Atom Nanozymes.Nano-micro letters · 2026Review
- The Potential of α-Mangostin-Loaded Chitosan/Collagen Nanoparticles in Hydrogel Formulation for Enhanced Wound Healing.Nanotechnology, science and applications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Conventional treatments for hepatocellular carcinoma (HCC) lack efficacy and targeting abilities. Photodynamic therapy (PDT) has emerged as a promising alternative for targeted and minimally invasive tumor treatments. However, many biomaterials used in PDT pose biosafety concerns and insufficient enzyme activity often leads to limited reactive oxygen species (ROS) production, resulting in poor PDT efficacy. Single-atom nanoenzymes have attracted much research attention as a novel type of high-performance nanoenzymes. Methods: In this study, we prepared black phosphorus nanosheets (BP) with good biocompatibility as a platform and loaded single-atom gold nanoenzymes onto BP nanosheets to treat HCC. To enhance the stability and targeting ability of the nanohybrid, it was PEGylated and modified with folate (FA) targeting molecules. Results: The designed BP/single-atom nanoenzyme platform can target tumor tissues and generate substantial amounts of reactive oxygen species (ROS), demonstrating biocompatibility and improved catalytic activity. Conclusion: The nanoplatform effectively targets HCC and enhances PDT efficacy by increasing ROS production, offering a promising approach for HCC treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.